Home Bristol-Myers Squibb

Bristol-Myers Squibb

In operation
Post-IPO Round
Biopharmaceutical and Nutritional Product R&D and Sales
Basic
Enterprise Profile
LinkedIn

Basic Information

Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products through its subsidiaries.The company is divided into two segments: the Pharmaceutical segment and the Nutrition segment. The Pharmaceutical segment consists of global pharmaceuticals and international consumer healthcare businesses. The Nutrition segment operates through the company's subsidiary, Mead Johnson Nutrition Company (Mead Johnson).
Bristol-Myers Squibb Company
NewYork,NewYork,United States of America
more than 500 people
January 01, 1887
--

Enterprise Profile

Industrial Sector
Nutritional Supplement Manufacturing New Drug Development Manufacture of Chemical Pharmaceutical Preparations Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology Protein Technology
Concept
Therapeutic Products Department of Pharmacy Ovarian Cancer Breast Cancer # Liver Cancer Lung Cancer Gastric Cancer Esophageal Cancer Lymphoma Colorectal Cancer Prostate Cancer Leukemia
Application Scenarios
Innovative Drugs Monoclonal Antibody Bispecific Antibody ADC (Antibody-Drug Conjugate) Cell and Gene Therapy AI+Pharmaceuticals Novel Coronavirus